Associate Professor, Medicine, University of Washington School of Medicine

Hematology

Thomas Chauncey practices Hematology. He graduated from Rush Medical College. Thomas R. Chauncey, MD is a published doctor as well. He has 38 publications published. The latest was: Pretransplant minimal residual disease predicts survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation in complete remission.

Publications

---

• Pretransplant minimal residual disease predicts survival in mantle cell Lymphoma patients undergoing autologous stem cell transplantation in complete remission.
• Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell Lymphoma.
• Fibrosing Cholestatic Hepatitis C After Hematopoietic Cell Transplantation: Report of 3 Fatal Cases.
• A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
• Autologous transplant for relapsed follicular Lymphoma: impact of pre-transplant rituximab sensitivity.
• Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial.
• Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation.
• Graft-versus-host disease and Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
• Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic Cell transplantation: prognostic relevance of the initial CD3+ T Cell ...
• The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
• Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic Cell transplantation for advanced hematologic malignancies.
• Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving Hig...
• Limiting the daily total nucleated Cell dose of cryopreserved peripheral blood stem Cell products for autologous transplantation improves infusion-related safety with ...
• Nonmyeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high risk Acute lymphoblastic leukemia.
• Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with Acute myeloid leukemia.
• Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem Cell transplantation and immunologic recovery in patients with hemat...
• What is the role for donor natural killer Cells after nonmyeloablative conditioning?
• Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative alloGrafting.
• Five-year follow-up of patients with advanced chronic lymphocytic Leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
• Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with Myelodysplastic syndromes.
• Hematopoietic Cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloab...
• Reduced-intensity conditioning followed by allogeneic hematopoietic Cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disord...
• Relapse risk in patients with malignant Diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
• Extended mycophenolate mofetil and shortened cyclosporine failed to reduce Graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloab...
• Nonmyeloablative unrelated donor hematopoietic Cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
• Factors associated with outcomes in allogeneic hematopoietic Cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic Cell tran...
• Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear Cell transplantation after nonmyeloablative conditioning: the effect of po...
• Extending postGrafting cyclosporine decreases the risk of severe Graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
• Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic Leukemia.
• HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid Leukemia.
• Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
• Effects of race on survival after stem Cell transplantation.
• Kinetics of enGraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
• Allogeneic hematopoietic stem Cell transplantation for myelofibrosis.
• AlloGrafting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
• Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community don...
• Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem Cell transplantation from related and unrelated donors in patients with myelodysplastic s...

Schools

---

• Rush University

• University Wash Affil Hosps

• University Wash Med Center

• University of Washington

Conditions Treated

---

• Acute Leukemia
• Anemia
• Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
• Brain Cancer
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology
• Hematology

Accepted Insurances

---

Education

---

• University of Washington
• Rush Medical College

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Stephen H. Petersdorf, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Paul C. Hendrie, MD This Doctor is OpenDoctor Recommended.
	Dr. Erin D. Ellis, MD This Doctor is OpenDoctor Recommended.
	Dr. Vikramsinh M. Dabhi, MD This Doctor is OpenDoctor Recommended.
	Dr. Sioban B. Keel, MD This Doctor is OpenDoctor Recommended.
	Dr. Diana F. Hausman, MD
	Dr. Raya Mawad, MD This Doctor is OpenDoctor Recommended.
	Dr. Shailender Bhatia, MD This Doctor is OpenDoctor Recommended.
	Dr. Henry O. Otero, MD
	Dr. Filippo Milano, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer M. Specht, MD This Doctor is OpenDoctor Recommended.
	Dr. Emily A. Stevens, MD This Doctor is OpenDoctor Recommended.
	Dr. Maria T. Zudaire, MD
	Carrie A. Graham, NP

---

Doctor Directory | TOS | twitter | FB | Angel | blog